Breathing Interventions for Relaxation: Dosing Through Extended Exhale

Sponsor
Vanderbilt University Medical Center (Other)
Overall Status
Completed
CT.gov ID
NCT02870868
Collaborator
National Center for Complementary and Integrative Health (NCCIH) (NIH)
99
1
2
26.2
3.8

Study Details

Study Description

Brief Summary

Breathing exercises are categorized as a mind-body practice. One in ten adults in the U.S. use breathing exercises for health purposes. The aim of this project is to examine if different slow breathing has different physiological and psychological effects.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Slow breathing
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
99 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Treatment
Actual Study Start Date :
Oct 14, 2016
Actual Primary Completion Date :
Dec 19, 2018
Actual Study Completion Date :
Dec 19, 2018

Arms and Interventions

Arm Intervention/Treatment
Experimental: Slow breathing with exhale greater than inhale

Behavioral: Slow breathing
Slow breathing techniques from yoga

Experimental: Slow breathing with exhale equal to inhale

Behavioral: Slow breathing
Slow breathing techniques from yoga

Outcome Measures

Primary Outcome Measures

  1. Magnitude of change in high frequency heart rate variability [Baseline, 6 weeks, and 12 weeks]

    Measure of parasympathetic tone

  2. Magnitude of change in PROMIS Anxiety scale [Baseline, 6 weeks, and 12 weeks]

    Measure of psychological stress

Secondary Outcome Measures

  1. Magnitude of change in baroreflex sensitivity [Baseline, 6 weeks, and 12 weeks]

    Measure of parasympathetic tone

  2. Magnitude of change in PROMIS Depression scale [Baseline, 6 weeks, and 12 weeks]

    Measure of negative affect

Other Outcome Measures

  1. Magnitude of change in Perceived Stress Scale [Baseline, 6 weeks, and 12 weeks]

    Measure of changes in stress

  2. Magnitude of change in Anxiety Sensitivity Index-3 [Baseline, 6 weeks, and 12 weeks]

    Measure of changes in stress

  3. Magnitude of change in Beck Anxiety Inventory [Baseline, 6 weeks, and 12 weeks]

    Measure of changes in stress

  4. Magnitude of change in Body Vigilance Scale [Baseline, 6 weeks, and 12 weeks]

    Measure of changes in stress

  5. Magnitude of change in Panic Disorder Severity Scale [Baseline, 6 weeks, and 12 weeks]

    Measure of changes in stress

Eligibility Criteria

Criteria

Ages Eligible for Study:
30 Years to 60 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Age 30 to 60 years

  • English speaking

Exclusion Criteria:
  • Hypertension

  • Heart disease: history of coronary artery disease, myocardial infarction, significant valvular disease, or congestive heart failure

  • Diabetes

  • Renal disease

  • Anxiety disorder

  • Depression

  • Other psychiatric conditions including schizophrenia or bipolar disorder

  • Attention-deficit-disorder or Attention-deficit-hyperactivity disorder

  • Musculoskeletal condition limiting capacity to perform simple movements such as chronic lower back pain or neck pain

  • Pulmonary disorder (asthma, chronic obstructive lung disease, obstructive sleep apnea)

  • Smoker

  • Currently taking blood pressure medications, oral diabetic medication or insulin

  • Current participation in a mind-body practice/program

  • Current cancer other than non- melanoma skin cancer

  • Regular swimmer

  • Plays wind or brass musical instruments

After two weeks during screening period unable to:
  • Breathe 8 or less a minute

  • Breathe 3 or less breaths a minute

  • Practiced less than 3 times a week

Contacts and Locations

Locations

Site City State Country Postal Code
1 Vanderbilt University Medical Center Nashville Tennessee United States 37232

Sponsors and Collaborators

  • Vanderbilt University Medical Center
  • National Center for Complementary and Integrative Health (NCCIH)

Investigators

  • Principal Investigator: Gurjeet Birdee, MD, Vanderbilt University Medical Center

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Alfredo Gamboa, Assoc. Professor, Vanderbilt University Medical Center
ClinicalTrials.gov Identifier:
NCT02870868
Other Study ID Numbers:
  • 160817
First Posted:
Aug 17, 2016
Last Update Posted:
Apr 5, 2019
Last Verified:
Apr 1, 2019
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Keywords provided by Alfredo Gamboa, Assoc. Professor, Vanderbilt University Medical Center

Study Results

No Results Posted as of Apr 5, 2019